Filing Details
- Accession Number:
- 0001179110-18-013352
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-03 13:33:58
- Reporting Period:
- 2018-11-28
- Accepted Time:
- 2018-12-03 13:33:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 896264 | Usana Health Sciences Inc | USNA | Medicinal Chemicals & Botanical Products (2833) | 870500306 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1353496 | Kevin Guest | 3838 West Parkway Blvd Salt Lake City UT 84120 | C.e.o. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-11-28 | 14,369 | $70.75 | 16,208 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-11-28 | 14,369 | $120.86 | 1,839 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-11-29 | 5,059 | $70.75 | 6,898 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-11-29 | 5,059 | $121.26 | 1,839 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Settled Stock Appreciation Rights | Disposition | 2018-11-28 | 35,008 | $0.00 | 35,008 | $70.75 |
| Common Stock | Stock Settled Stock Appreciation Rights | Disposition | 2018-11-29 | 12,183 | $0.00 | 12,183 | $70.75 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 72,183 | 2018-09-01 | 2020-03-01 | No | 4 | M | Direct |
| 60,000 | 2018-09-01 | 2020-03-01 | No | 4 | M | Direct |
Footnotes
- The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II.
- Weighted average price $120.8628. Price range in multiple transactions was $120.70 to $121.18 inclusively.
- Weighted average price $121.2634. Price range in multiple transactions was $121.00 to $121.87 inclusively.
Billionaire Hedge Funds
